The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review

• Päätekijät: Azita Nabizadeh (Tekijä), Bahman Amani (Tekijä), Maliheh Kadivar (Tekijä), Mahdi Toroski (Tekijä), Akbar Abdollahi Asl (Tekijä), Yahya Bayazidi (Tekijä), Mahdi Mojahedian (Tekijä), Majid Davari (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Gaucher's disease (GD) is one of the most common lysosomal diseases in humans. It results from β-glucosidase deficiency and leads to necrosis, especially in macrophages with the accumulation of glucosylceramidase in cells. Most of the deleterious effects of the disease are seen in the liver, sp...